Baptist Health Heart & Vascular Care to Host 43rd Annual Echocardiography and Structural Heart Symposium - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Baptist Health Heart & Vascular Care to Host 43rd Annual Echocardiography and Structural Heart Symposium

Baptist Health South Florida will host the Baptist Health Heart & Vascular Care 43rd Annual Echocardiography and Structural Heart Symposium on Oct. 2-3 at the Loews Coral Gables Hotel.

  • By

  • August 28, 2026

  • 4 min

Share

Objective:

To explore the latest advances in cardiac imaging, valvular heart disease, and structural heart interventions.

Approach:
  • Event Details: The symposium will take place on Oct. 2-3 at the Loews Coral Gables Hotel, directed by Elliott Elias, M.D.
  • Target Audience: Designed for physicians, sonographers, and medical professionals involved in structural heart disease diagnosis and treatment.
  • Topics Covered: Includes echocardiographic assessment, 3D imaging, strain imaging, cardiac CT and MRI, and multimodality imaging for structural heart procedures.
Key Findings:
  • Advanced imaging is crucial for understanding patient conditions and treatment strategies.
  • Collaboration among clinicians enhances individualized patient care.
  • Emerging treatment strategies for aortic, mitral, and tricuspid valve disease will be discussed.
Interpretation:

The symposium aims to foster collaboration and knowledge sharing among cardiovascular specialists to improve patient outcomes.

Limitations:
  • No specific data or outcomes from previous symposia were provided.
  • The article does not detail participant feedback or post-symposium evaluations.
Conclusion:

The symposium emphasizes the importance of multidisciplinary decision-making in treating complex valve diseases.

Sources:

Original Source(s)

Baptist Health Heart & Vascular Care to Host 43rd Annual Echocardiography and Structural Heart Symposium

  • by

  • August 28, 2026

Related Content

Can Sugammadex Lower Postsurgical Pulmonary Complications?

A large international randomized trial found fewer postoperative pulmonary complications with sugammadex vs. neostigmine following major abdominal or thoracic surgery, although the difference was driven primarily by reduced atelectasis.

ASE Plenary: Progress, Priorities, and What’s Next

Efforts to align, sustain, and engage drove a year of growth for ASE.

Real-world characteristics and management of ventricular tachycardias in ICD patients: Data from the VIDEO registry